☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
three
Sangamo Signs a Worldwide License Agreement with Novartis to Develop Genomic Therapies for Three Neurodevelopmental Targets
July 30, 2020
Three Pharma Companies Launch Favipiravir to Treat COVID-19 in India
July 27, 2020
Merck Reports Three Major Initiatives Focusing on Developing Vaccine Against COVID-19
May 26, 2020
Three Global Pharmaceutical Companies Launch Worker Volunteer Programs to Combat COVID-19
April 2, 2020
Bayer Signs a Three Year Multi Target AI-based Agreement with Exscientia to Treat Cardiovascular and Oncology Diseases
January 10, 2020
Mylan Voluntarily Recalls Nationwide Three Lots of Nizatidine Capsules USP Due to Trace Amounts of NDMA (N-Nitrosodimethylamine)
January 9, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.